Nucleoside analogs with carboxamidine modified monocyclic base
作者： Kandasamy Ramasamy , Zhi Hong , Robert Tam , Johnson Lau
DOI:
关键词:
摘要: Novel nucleoside analog compounds are disclosed. The novel or pharmaceutically acceptable esters salts thereof may be used in pharmaceutical compositions, and such compositions to treat an infection, infestation, a neoplasm, autoimmune disease. also modulate aspects of the immune system, including modulation Type 1 2 activity.
lens.org 参考文章(87)
Ryuzo Ueno, Sachiko Kuno, Ryuji Ueno, Treatment of diseases caused by viruses ,(1988)
Joseph T. Witkowski, Roland K. Robins, 1-(β,-D-ribofuranosyl)-1,2,4-triazole acid esters ,(1974)
Robert A. Earl, Leroy B. Townsend, 7-substituted nucleoside compounds ,(1975)
Edward P. Gamson, Michael Goodman, Immunostimulating 7-deaza-7-oxa-and 7-deaza-7-thia-analogs of 8-substituted-guanine-9-(1'-beta-d-aldoglycosidyl) derivatives, compositions and methods ,(1989)
Gail Patstone, Nora E Sarvetnick, Judith Harbertson, Linda M. Bradley, Valérie C. Asensio, Iain L. Campbell, Nigel Woolf, Li Karine Schioetz, Troy Krahl, Islet-Specific Th1, But Not Th2, Cells Secrete Multiple Chemokines and Promote Rapid Induction of Autoimmune Diabetes Journal of Immunology. ,vol. 162, pp. 2511- 2520 ,(1999)
Shripad S. Bhagwat, Marlon Daniel Cowart, Heterocyclic substituted cyclopentane compounds ,(1996)
Kanda S. Ramasamy, Robert Tam, Methods for treating diseases with tirazole and pyrrolo-pyrimidine ribofuranosyl nucleosides ,(2000)
Roland K. Robins, Ganapathi R. Revankar, 1,2,4-Thiadiazolidine-3,5-dione ,(1977)
William A. Carter, dsRNAs for combination therapy in the treatment of viral diseases ,(1987)
William A. Carter, Treatment of human viral infection by dsrna combined with viral inhibitors ,(1988)